The Food and Drug Administration (FDA or Agency) is announcing the availability of a final guidance for industry entitled ``Selection of the Appropriate Package Type Terms and Recommendations for Labeling Injectable Medical Products Packaged in Multiple-Dose, Single-Dose, and Single-Patient-Use Containers for Human Use.'' This guidance finalizes the draft guidance issued October 22, 2015, which provides recommendations on the selection of appropriate package type terms and selection of appropriate discard statements for injectable medical products for human use, packaged in multiple-dose, single-dose, and single-patient-use containers.
Document
Selection of the Appropriate Package Type Terms and Recommendations for Labeling Injectable Medical Products Packaged in Multiple-Dose, Single-Dose, and Single-Patient-Use Containers for Human Use; Guidance for Industry; Availability
The Food and Drug Administration (FDA or Agency) is announcing the availability of a final guidance for industry entitled ``Selection of the Appropriate Package Type Terms and R...
Legal Citation
Federal Register Citation
Use this for formal legal and research references to the published document.
83 FR 49933
Web Citation
Suggested Web Citation
Use this when citing the archival web version of the document.
“Selection of the Appropriate Package Type Terms and Recommendations for Labeling Injectable Medical Products Packaged in Multiple-Dose, Single-Dose, and Single-Patient-Use Containers for Human Use; Guidance for Industry; Availability,” thefederalregister.org (October 3, 2018), https://thefederalregister.org/documents/2018-21531/selection-of-the-appropriate-package-type-terms-and-recommendations-for-labeling-injectable-medical-products-packaged-in.